Clinical Trials Browser

Withdrawn × Gliosarcoma × Nivolumab × Clear all

NCT03014804 2020-07-24

Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma

Phase 2 Withdrawn

Glioblastoma, Oligodendroglioma, Gliosarcoma